Yakira Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Yakira Capital Management’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100,000	Closed	-$221K	–	393
2023 Q2	$221K	Buy	+100,000	New	+$207K	0.06%	142

Yakira Capital Management's PRTK Position: Q3 2023 in Review

Yakira Capital Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 100,000 shares — an estimated $221K sold.

Yakira Capital Management first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $221K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Yakira Capital Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Yakira Capital Management sold 100,000 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $221K.
Yakira Capital Management first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
Yakira Capital Management's Paratek Pharmaceuticals, Inc. position peaked at $221K in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Yakira Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.